Clinical Trial Update: RFA Versus SBRT for Recurrent Small HCC [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing radiofrequency ablation (RFA) versus stereotactic body radiotherapy (SBRT) for recurrent small hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED